The short-lived effects of hormone therapy on cognitive function

The Effects of Estrogen on Brain Function

Volumn , Issue , 2006, Pages 46-78

  Hogervorst, Eva ^a,b  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947655616     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (130)

1. Albertazzi P, Natale V, Barbolini C., et al 2000. The effect of tibolone versus continuous combined norethisterone acetate and oestradiol on memory, libido and mood of postmenopausal women: a pilot study. Maturitas 36:223-29.
2. Amaducci LA, Fratiglioni L, Rocca W.A., et al 1986. Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology 36:922-31.
3. Anderson GL, Limacher M, Assaf A.R., et al 2004. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291:1769-71.
4. Asthana S, Baker LD, Craft S, et al 2001. High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology 57:605-12.
5. Asthana S, Craft S, Baker L.D., et al 1999. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with AD: results of a placebocontrolled, double-blind pilot study. Psychoneuroendocrinology 24:657-77.
6. Ayatollahi SM, Dowlatabadi E, Ayatollahi SA 2002. Age at menarche in Iran. Ann Hum Biol 29:355-62.
7. Balderischi M, DiCarlo A, Lepore V., et al 1998. Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurology 50:996-1002.
8. Barrett-Connor E. 1998. Rethinking estrogen and the brain. J Am Geriatr Soc 46: 918-20.
9. Barrett-Connor E., Goodman-Gruen D. 1999. Cognitive function and endogenous sex hormones in older women. J Am Geriatr Soc 47:1289-93.
10. Barrett-Connor E., Kritz-Silverstein D. 1999. Gender differences in cognitive function with age: the Rancho Bernardo Study. J Am Geriatr Soc 47:159-64.
11. Binder EF, Schechtman KB, Birge S.J., et al 2001. Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas 38:137-46.
12. Borenstein-Graves A., White E, Koepsell T.D., et al 1990. A case-control study of Alzheimer's disease. Ann Neurol 28:766-74.
13. Brenner DE, Kukull WA, Stergachis A, et al 1994. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol 140:262-67.
14. Broe GA, Henderson AS, Creasey H, et al 1990. A case-control study of Alzheimer's disease in Australia. Neurology 40:1698-1707.
15. Burkhardt MS, Foster JK, Laws S.M., et al 2004. Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4. J Alzheimers Dis 6:221-28.
16. Caldwell BM. 1954. An evaluation of psychological effects of sex hormone administration in aged women. II. Results of therapy after 18 months. J Gerontol 9:168-74.
17. Carlson LE, Sherwin BB 1998. Steroid hormones, memory and mood in a healthy elderly population. Psychoneuroendocrinology 30:583-603.
18. *3 polymorphism and ovarian cancer in a Caucasian population. Int J Biol Markers 19:160-63.
19. Cerhan JR, Folsom AR, Mortimer J.A., et al 1998. Correlates of cognitive function in middle aged adults. Gerontology 44:95-105.
20. Cunningham CJ, Sinnott M, Denihan A., et al 2001. Endogenous sex hormone levels in postmenopausal women with AD. J Clin Endocrinol Metab 86:1099-1103.
21. Davis SR. 2002. The effects of tibolone on mood and libido. Menopause 9:162-70.
22. Den Heijer T., Geerlings MI, Hofman A, et al 2003. Higher estrogen levels are not associated with larger hippocampi and better memory performance. Arch Neurol 60:213-20.
23. Ditkoff EC, Crary WG, Cristo M, et al 1991. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 78:991-95.
24. Drake EB, Henderson VW, Stanczyk F.Z., et al 2000. Associations between circulating sex steroid hormones and cognition in normal elderly women. Neurology 54:599-603.
25. Duffy R, Wiseman H, File SE 2003. Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacol Biochem Behav 75:721-29.
26. Duka T, Tasker R, McGowan FF 2000. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology 149:129-39.
27. Dunkin J, Rasgon N, Wagner-Steh K, et al 2005. Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women. Psychoneuroendocrinology 30:284-96.
28. Farrag AK, Khedr EM, Abdel-Aleem H, et al 2002. Effect of surgical menopause on cognitive functions. Dement Geriatr Cogn Disord 13:193-98.
29. Fedor-Freyberg P. 1977. The influence of estrogens on the well-being and mental performance in climacteric and postmenopausal women. Acta Obstet Gynecol Scand 64:12-20.
30. File SE, Heard JE, Rymer J. 2002. Trough oestradiol levels associated with cognitive impairment in post-menopausal women after 10 years of oestradiol implants. Psychopharmacology (Berl) 161:107-12.
31. Fillit HM, Ashby D, Weinreb H., et al 1986. Estrogen levels in postmenopausal women with senile dementia-Alzheimer's type (SDAT) are significantly lower than matched controls. Soc Neurosci Abstr 12A529. 11.
32. Fluck E, File SE, Rymer J. 2002. Cognitive effects of 10 years of hormone-replacement therapy with tibolone. J Clin Psychopharmacol 22:62-67.
33. Geerlings MI, Launer LJ, de Jong FH, et al 2003. Endogenous estradiol and risk of dementia in women and men: the Rotterdam Study. Ann Neurol 53:607-15.
34. Geerlings MI, Ruitenberg A, Witteman J.C., et al 2001. Reproductive period and risk of dementia in postmenopausal women. JAMA 285:1475-81.
35. Gibbs R. 2004. E-mail communication to E. Hogervorst, November 11.
36. Goebel JA, Birge SJ, Price S.C., et al 1995. Estrogen replacement therapy and postural stability in the elderly. Am J Otol 16:470-74.
37. Goodnick PJ, Chaudry T, Artadi J., et al 2000. Women's issues in mood disorders. Expert Opin Pharmacother 1:903-16.
38. Grady D, Yaffe K, Kristof M., et al 2002. Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/Progestin Replacement Study. Am J Med 113:543-48.
39. Hackman BW, Galbraith D. 1977. Six month study of oestrogen therapy with piper-azine oestrone sulphate and its effects on memory. Curr Med Res Opin 4:21-27.
40. Hamajima N, Matsuo K, Tajima K., et al 2001. Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan. Int J Clin Oncol 6:13-18.
41. Henderson VW. 2004. Hormone therapy and Alzheimer's disease: benefit or harm? Expert Opin Pharmacother 5:389-406.
42. Henderson VW, Guthrie JR, Dudley E.C., et al 2003. Estrogen exposures and memory at midlife: a population-based study of women. Neurology 60:1369-71.
43. Henderson VW, Paganini-Hill A, Emanuel C.K., et al 1994. Estrogen replacement therapy in older women: comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol 51:896-900.
44. Henderson VW, Paganini-Hill A, Miller B.L., et al 2000. Estrogen for Alzheimer's disease in women. Neurology 54:295-301.
45. Heyman A, Wilkinson WE, Stafford J.A., et al 1984. Alzheimer's disease: a study of epidemiological aspects. Ann Neurol 15:335-41.
46. Hogervorst E, Bandelow S, Hart J Jr, et al 2004. Telephone word-list recall tested in the rural aging and memory study: two parallel versions for the TICS-M. Int J Geriatr Psychiatry 19:875-80.
47. Hogervorst E, Boshuisen M, Riedel W.J., et al 1999. The effect of hormone replacement therapy on cognitive function in elderly women. Psychoneuroendocrinology 24: 43-68.
48. Hogervorst E, De Jager C, Budge MM, et al 2004. Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women. Psychoneuroendocrinology 29:405-21.
49. Hogervorst E, Mendes Ribeiro H, Molyneux A, et al 2002. Serum homocysteine, cerebrovascular risk factors and white matter low attenuation on CT scans in patients with post-mortem confirmed AD. Arch Neurol 59:787-93.
50. Hogervorst E, Smith AD 2002. The interaction of serum folate and estradiol levels in Alzheimer's disease. Neuroendocrinol Lett 23:155-60.
51. Hogervorst E, Williams J, Budge M., et al 2000. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 101:485-512.
52. Hogervorst E, Williams J, Combrinck M., et al 2003. Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method. Eur J Endocrinol 148:67-72.
53. Hogervorst E, Yaffe K, Richards M., et al 2002a. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst Rev 3:CD003122.
54. Hogervorst E, Yaffe K, Richards M., et al 2002b. Hormone replacement therapy to maintain cognitive function in women with dementia. Cochrane Database Syst Rev 3: CD003799.
55. Huppert FA, Van Niekerk JK. 2001. Dehydroepiandrosterone (DHEA) supplementation for cognitive function. Cochrane Database Syst Rev 2:CD000304.
56. Jacobs DM, Tang M-X, Stern Y, et al 1998. Cognitive function in non-demented older women who took estrogen after menopause. Neurology 30:368-73.
57. Jobst KA, Smith AD, Szatmari M, et al 1992. Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 340:1179-83.
58. Kato I, Toniolo P, Akhmedkhanov A., et al 1998. Prospective study of factors influencing the onset of natural menopause. J Clin Epidemiol 51:1271-76.
59. Kawas C, Resnick S, Morrison A., et al 1996. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease. Neurology 48:1517-21.
60. Kim SH, Ensunsa JL, Zhu Q.Y., et al 2004. An 18-month follow-up study on the influence of smoking on blood antioxidant status of teenage girls in comparison with adult male smokers in Korea. Nutrition 20:437-44.
61. Kinsinger LS, Harris R, Woolf S.H., et al 2002. Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137: 59-69.
62. Kreijkamp-Kaspers S., Kok L, Grobbee D.E., et al 2005. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized, controlled trial. Obstet Gynecol Surv 60:41-43.
63. Kris-Etherton P.M., Hecker KD, Bonanome A, et al 2002. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 113: 71S-88S.
64. Kritz-Silverstein D., Von Muhlen D, Barrett-Connor E, et al 2003. Isoflavones and cognitive function in older women: the Soy and Postmenopausal Health in Aging (SOPHIA) study. Menopause 10:196-202.
65. Krug R, Molle M, Dodt C., et al 2003. Acute influences of estrogen and testosterone on divergent and convergent thinking in postmenopausal women. Neuropsychopharmacology 28:1538-45.
66. Launer LJ, Andersen K, Dewy M.E., et al 1999. Rates and risk factors for dementia and Alzheimer's disease. Neurology 1:78-84.
67. LeBlanc ES, Janowsky J, Chan B.K., et al 2001. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 285:1489-99.
68. Lerner A, Koss E, Debanne S., et al 1997. Smoking and oestrogen replacement therapy as protective factors against AD. Lancet 349:403-4.
69. Linzmayer L, Semlitsch HV, Saletu B, et al 2001. Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients. Arzneimittelforschung 51:238-45.
70. Lokkegaard E, Pedersen AT, Laursen P, et al 2002. The influence of hormone replacement therapy on the aging-related change in cognitive performance: analysis based on a Danish cohort study. Maturitas 42:209-18.
71. Manly JJ, Merchant CA, Jacobs D.M., et al 2000. Endogenous estrogen levels and Alzheimer's disease among postmenopausal women. Neurology 54:833-37.
72. Matthews K, Cauley J, Yaffe K., et al 1999. Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc 47:518-23.
73. Matthews KA, Kuller LH, Wing R.R., et al 1996. Prior to use of estrogen replacement therapy: are users healthier than nonusers? Am J Epidemiol 143:971-78.
74. McKhann G, Drachmann D, Folstein M., et al 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-44.
75. McLay RN, Maki PM, Lyketsos CG 2003. Nulliparity and late menopause are associated with decreased cognitive decline. J Neuropsychiatry Clin Neurosci 15:161-67.
76. Meek MD, Finch GL 1999. Diluted mainstream cigarette smoke condensates activate estrogen receptor and aryl hydrocarbon receptor-mediated gene transcription. Environ Res 80:9-17.
77. Merchant C, Tang M-X, Albert S, et al 1999. The influence of smoking on the risk of Alzheimer's disease. Neurology 52:1408-12.
78. Mortel KF, Meyer JS 1995. Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatry Clin Neurosci 7:334-37.
79. Mulnard RA, Cotman CW, Kawas C, et al 2000. Estrogen replacement therapy for treatment of mild to moderate Alzheimer's disease. JAMA 283:1007-15.
80. Nappi RE, Sinforiani E, Mauri M., et al 1999. Memory functioning at menopause: impact of age in ovariectomized women. Gynecol Obstet Invest 47:29-36.
81. Nickelsen T, Lufkin EG, Riggs B.L., et al 1999. Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women. Psychoneuroendocrinology 24:115-28.
82. Paganini-Hill A., Clark LJ 2000. Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 64:165-76.
83. Paganini-Hill A., Henderson VW 1994. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 140:256-61.
84. Paganini-Hill A., Henderson VW 1996. The effect of hormone replacement therapy lipoprotein cholesterol levels and other factors on a clock drawing task in older women. J Am Geriatr Soc 44:818-22.
85. Pan H-A, Wang S-T, Pai M-C, et al 2003. Cognitive function variations in postmenopausal women treated with continuous, combined HT or tibolone: a comparison. J Reprod Med 48:375-80.
86. Paoletti AM, Congia S, Lello S., et al 2004. Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology 62:301-3.
87. Petitti DB, Buckwalter JG, Crooks V.C., et al 2002. Prevalence of dementia in users of hormone replacement therapy as defined by prescription data. J Gerontol A Biol Sci Med Sci 57:M532-38.
88. Phillips SM, Sherwin BB 1992. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17:485-95.
89. Polo-Kantola P., Portin R, Polo O., et al 1998. The effect of short-term estrogen replacement therapy on cognition: a randomized double-blind, cross-over trial in postmenopausal women. Obstet Gynecol 91:459-66.
90. Rapp SR, Espeland MA, Shumaker S.A., et al 2003. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2663-72.
91. Regestein QR, Friebely J, Shifren J., et al 2001. Neuropsychological effects of methyl-testosterone in women using menopausal hormone replacement. J Womens Health Gend Based Med 10:671-76.
92. Relkin N, McRae T, Reuss V., et al 2002. Estrogen does not enhance the efficacy of donepezil in the treatment of women with Alzheimer's disease. Paper presented at the 8th International Conference on AD and Related Disorders (p. 53). Stockholm, Sweden.
93. Rigaud AS, Andre G, Vellas B., et al 2003. No additional benefit of HT on response to rivastigmine in menopausal women with AD. Neurology 60:148-49.
94. Ross LA, Alder EM, Cawood E.H., et al 1999. Psychological effects of hormone replacement therapy: a comparison of tibolone and a sequential estrogen therapy. Psychosom Obstet Gynaecol 20:88-96.
95. Rymer J, Wilson R, Ballard K. 2003. Making decisions about hormone replacement therapy. BMJ 326:322-26.
96. Sarrel PM. 1989. Effects of ovarian steroids on the cardiovascular system. In The Circulation of the Female from the Cradle to the Grave, ed. J Ginsberg, 112-40. Carnford, U.K.: Parthenon Publishing.
97. Schneider LS, Farlow MR, Henderson V.W., et al 1996. Effects of estrogen replacement therapy in response to tacrine in patients with Alzheimer's disease. Neurology 46:1580-84.
98. Seshadri S, Zornberg G, Derby L.E., et al 2001. Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. Arch Neurol 58:435-40.
99. Sharp L, Cardy AH, Cotton S.C., et al 2004. CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. A HuGE review. Am J Epidemiol 160:729-40.
100. Shaywitz SE, Shaywitz BE, Pugh K.R., et al 1999. Effects of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 281:1197-202.
101. Sherwin BB. 1988. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13:345-57.
102. Sherwin BB. 1994. Estrogenic effects on memory in women. Ann N Y Acad Sci 743: 213-30.
103. Shumaker SA, Legault C, Rapp S.R., et al 2003. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. JAMA 289:2651-62.
104. Slooter AJC, Bronzova J, Witteman JCM, et al 1999. Estrogen use and early onset Alzheimer's disease: a population based study. J Neurol Neurosurg Psychiatry 67: 779-81.
105. Smith AD. 2002. Homocysteine, B vitamins, and cognitive deficit in the elderly. Am J Clin Nutr 75:785-86.
106. Steffens DC, Noron MC, Plassman B.L., et al 1999. Enhanced cognitive performance with estrogen use in nondemented community dwelling older women. J Am Geriatr Soc 47:1171-75.
107. Szklo M, Cerhan J, Diez-Roux AV, et al 1996. Estrogen replacement therapy and cognitive functioning in the Atherosclerotic Risk in Communities (ARIC) study. Am J Epidemiol 144:1048-57.
108. Tang M-X, Jacobs D., Stern Y, et al 1996. Effect of estrogen during menopause on risk and age of onset of Alzheimer's disease. Lancet 348:429-32.
109. Thal LJ, Thomas RG, Mulnard R, et al 2003. Estrogen levels do not correlate with improvement in cognition. Arch Neurol 60:209-12.
110. Toran-Allerand D. 2004. Oral remarks at a meeting, Neurobiology and Neuroendocrinology of Aging, Bregenz, Austria, July 18-23.
111. Vanhulle G, Demol R. 1976. A double-blind study into the influences of estriol on a number of psychological tests in postmenopausal women. In Consensus on Menopausal Research, ed. PA van Keep, RB Greenblatt, M Albeaux-Fernet, 94-99. London: MTP Press.
112. Verghese J, Kuslansky G, Katz M. 2000. Surgically menopausal women on estrogen have better cognitive performance. Neurology 54:A210-11.
113. Wang PN, Liao SQ, Liu R.S., et al 2000. Effects of estrogen on cognition, mood, and cerebral blood flow in AD. Neurology 54:2061-66.
114. Waring SC, Rocca WA, Petersen R.C., et al 1999. Postmenopausal estrogen replacement therapy and risk of AD. Neurology 52:965-70.
115. White LR, Petrovitch H, Ross G.W., et al 2000. Brain aging and midlife tofu consumption. J Am Coll Nutr 19:242-55.
116. Wisniewski AB, Nguyen TT, Dobs AS 2002. Evaluation of high-dose estrogen and highdose estrogen plus methyltestosterone treatment on cognitive task performance in postmenopausal women. Horm Res 58:150-55.
117. Wolf OT. 2003. Cognitive functions and sex steroids. Ann Endocrinol (Paris) 64:158-61.
118. Wolf OT, Kirschbaum C. 2002. Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm Behav 41:259-66.
119. Wolf OT, Kudielka BM, Hellhammer D.H., et al 1999. Two weeks of transdermal estradiol treatment in postmenopausal elderly women and its effect on memory and mood. Psychoneuroendocrinology 24:727-41.
120. Woo J, Lau E, Ho S.C., et al 2003. Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause. Menopause 10:352-61.
121. Wren BG. 1998. Megatrials of hormonal replacement therapy. Drugs Aging 12:343-48.
122. Wu FC, von Eckardstein A. 2003. Androgens and coronary artery disease. Endocr Rev 24:183-217.
123. Yaffe K, Grady D, Pressman A., et al 1998. Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women. J Am Geriatr Soc 46:816-21.
124. Yaffe K, Haan M, Byers A., et al 2000. Estrogen use, ApoE, and cognitive decline. Neurology 54:1949-53.
125. Yaffe K, Krueger K, Sarkar S., et al 2001. Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med 344:1207-13.
126. Yaffe K, Lui L-Y, Grady D, et al 2000. Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet 356:708-12.
127. Yaffe K, Sawaya G, Lieberburg I., et al 1998. Estrogen therapy in postmenopausal women. JAMA 279:688-95.
128. Yoon B-K, Kim D.K., Kang Y., et al 2003. Hormone replacement therapy in postmenopausal women with Alzheimer's disease: a randomized, prospective study. Fertil Steril 79:274-80.
129. Zandi PP, Carlson MC, Plassman B.L., et al 2002. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288:2123-29.
130. Zhao L, Chen Q, Diaz-Brinton R. 2002. Neuroprotective and neurotrophic efficacy of phytoestrogens in cultured hippocampal neurons. Exp Biol Med 227:509-10.